F, D. C., E, B., K, H., F, M., RR, B., O, d. R., . . . D, V. (2024). Impact of successful secondary hyperparathyroidism treatment on cardiovascular morbidity in patients with chronic kidney disease KDIGO stages G3b-5. Irish journal of medical science, 193(6), 2723. https://doi.org/10.1007/s11845-024-03770-x
Chicago Style (17th ed.) CitationF, Da Canal, Breuer E, Hübel K, Mikulicic F, Buechel RR, de Rougemont O, Seeger H, and Vetter D. "Impact of Successful Secondary Hyperparathyroidism Treatment on Cardiovascular Morbidity in Patients with Chronic Kidney Disease KDIGO Stages G3b-5." Irish Journal of Medical Science 193, no. 6 (2024): 2723. https://doi.org/10.1007/s11845-024-03770-x.
MLA (9th ed.) CitationF, Da Canal, et al. "Impact of Successful Secondary Hyperparathyroidism Treatment on Cardiovascular Morbidity in Patients with Chronic Kidney Disease KDIGO Stages G3b-5." Irish Journal of Medical Science, vol. 193, no. 6, 2024, p. 2723, https://doi.org/10.1007/s11845-024-03770-x.